Ascent Bio provides an AI scientist platform designed to augment drug development workflows for researchers. This agentic system accelerates scientific discovery by offering a unified, capable tool for complex research tasks. The platform aims to significantly increase the productivity of scientists engaged in pharmaceutical design and research.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional drug discovery methods are slow and costly, often requiring extensive manual screening and optimization of drug candidates. Exploring vast chemical spaces to identify molecules with desired therapeutic properties is a significant bottleneck in the drug development process.
Solution
Ascent Bio offers an AI-native molecule design platform that accelerates the drug discovery process by leveraging deep learning and latent space optimization. The platform enables rapid exploration of extensive chemical spaces, allowing drug developers to design and optimize drug candidates with greater speed and efficiency. By harnessing foundation models and integrating diverse data sources, Ascent Bio empowers researchers to create focused libraries tailored to specific therapeutic properties, ultimately accelerating the identification of promising drug leads.
Target Audience
Ascent Bio's primary customers are drug discovery teams and pharmaceutical companies seeking to accelerate their research and development efforts through AI-powered molecule design.
Features
- AI-driven molecule design leveraging deep learning and latent space optimization
- Rapid exploration of chemical spaces exceeding 10 billion molecules
- Ability to design libraries with multiple optimized properties tailored to project goals
- Foundation models trained to capture vital structure-property relationships
- Programmatic execution of hundreds of design tasks to understand chemical space exploration